SCHEMBL336544

SCHEMBL336544

CCCCCCC(OC(=O)CCCCC)C(CCCCCC)OC(=O)CCCCC

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.66
MAPT P10636 3/20 0.61
MAPK1 P28482 3/20 0.61
ALDH1A1 P00352 1/20 0.58
DGKA P23743 1/20 0.53
PRKCA P17252 1/20 0.53
PRKCE Q02156 1/20 0.53
PRKCQ Q04759 1/20 0.53
PRKCD Q05655 1/20 0.53
CYP1A2 P05177 2/20 0.49
MEN1 O00255 1/20 0.49
GMNN O75496 1/20 0.49
HSP90AA1 P07900 1/20 0.49
BLM P54132 1/20 0.49
KMT2A Q03164 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
NR1H4 Q96RI1 1/20 0.49
TP53 P04637 1/20 0.49
CYP2C9 P11712 1/20 0.49
TSHR P16473 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29929103 1.00 LMNA (0.66) LMNAMAPTMAPK1ALDH1A1DGKA
SCHEMBL424085 1.00 LMNA (0.66) LMNAMAPTMAPK1ALDH1A1DGKA
SCHEMBL28500439 1.00 LMNA (0.66) LMNAMAPTMAPK1ALDH1A1DGKA
SCHEMBL10021524 1.00 LMNA (0.66) LMNAMAPTMAPK1ALDH1A1DGKA
SCHEMBL10032088 1.00 LMNA (0.66) LMNAMAPTMAPK1ALDH1A1DGKA
SCHEMBL14666520 1.00 LMNA (0.66) LMNAMAPTMAPK1ALDH1A1DGKA
SCHEMBL421573 1.00 LMNA (0.66) LMNAMAPTMAPK1ALDH1A1DGKA
SCHEMBL14666437 1.00 LMNA (0.66) LMNAMAPTMAPK1ALDH1A1DGKA
SCHEMBL2138647 1.00 LMNA (0.66) LMNAMAPTMAPK1ALDH1A1DGKA
SCHEMBL28504201 1.00 LMNA (0.66) LMNAMAPTMAPK1ALDH1A1DGKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2121567-B1 DIESTER-BASED LUBRICANTS AND METHODS OF MAKING SAME CHEVRON USA INC (US) 2016-08-10 EP claimed
US-8586519-B2 Multi-grade engine oil formulations comprising a bio-derived ester component CHEVRON U.S.A. INC. (US) 2013-11-19 US claimed
EP-2470628-A2 MULTI-GRADE ENGINE OIL FORMULATIONS COMPRISING A BIO-DERIVED ESTER COMPONENT Chevron U.S.A. Inc. (US) 2012-07-04 EP claimed
WO-2011028329-A2 MULTI-GRADE ENGINE OIL FORMULATIONS COMPRISING A BIO-DERIVED ESTER COMPONENT CHEVRON U.S.A. INC. (US) 2011-03-10 WO claimed
US-20110053817-A1 MULTI-GRADE ENGINE OIL FORMULATIONS COMPRISING A BIO-DERIVED ESTER COMPONENT CHEVRON U.S.A. INC. (US) 2011-03-03 US claimed
CN-113853420-A Lubricant composition 巴斯夫欧洲公司 2021-12-28 CN disclosed
CN-112189047-A Lubricant composition 巴斯夫欧洲公司 2021-01-05 CN disclosed
EP-2671863-B1 Method of making diester-based lubricants CHEVRON USA INC (US) 2018-03-28 EP disclosed
EP-2470628-B1 MULTI-GRADE ENGINE OIL FORMULATIONS COMPRISING AN ESTER COMPONENT CHEVRON USA INC (US) 2017-08-30 EP disclosed
EP-2470628-B1 MULTI-GRADE ENGINE OIL FORMULATIONS COMPRISING AN ESTER COMPONENT CHEVRON USA INC (US) 2017-08-30 EP disclosed
EP-2250241-B1 SYNTHESIS OF DIESTER-BASED BIOLUBRICANTS FROM EPOXIDES CHEVRON USA INC (US) 2016-12-21 EP disclosed
EP-2250241-B1 SYNTHESIS OF DIESTER-BASED BIOLUBRICANTS FROM EPOXIDES CHEVRON USA INC (US) 2016-12-21 EP disclosed
US-20100120642-A1 SYNTHESIS OF DIESTER-BASED LUBRICANTS FROM ENZYMATICALLY-DIRECTED EPOXIDES CHEVRON U.S.A. INC. (US) 2010-05-13 US disclosed
US-20090285728-A1 ISOLATION AND SUBSEQUENT UTILIZATION OF SATURATED FATTY ACIDS AND ALPHA-OLEFINS IN THE PRODUCTION OF ESTER-BASED BIOLUBRICANTS CHEVRON U.S.A. INC. (US) 2009-11-19 US disclosed
US-20090285728-A1 ISOLATION AND SUBSEQUENT UTILIZATION OF SATURATED FATTY ACIDS AND ALPHA-OLEFINS IN THE PRODUCTION OF ESTER-BASED BIOLUBRICANTS CHEVRON U.S.A. INC. (US) 2009-11-19 US disclosed
US-20090198075-A1 SYNTHESIS OF DIESTER-BASED BIOLUBRICANTS FROM EPOXIDES CHEVRON U.S.A. INC. (US) 2009-08-06 US disclosed
WO-2009097041-A1 SYNTHESIS OF DIESTER-BASED BIOLUBRICANTS FROM EPOXIDES CHEVRON U.S.A. INC. (US) 2009-08-06 WO disclosed
US-20090159837-A1 REFRIGERATION OIL FROM GAS-TO-LIQUID-DERIVED AND BIO-DERIVED DIESTERS CHEVRON U.S.A., INC. 2009-06-25 US disclosed
US-20090159835-A1 REFRIGERATION OIL FROM GAS-TO-LIQUID-DERIVED AND BIO-DERIVED TRIESTERS CHEVRON U.S.A., INC. 2009-06-25 US disclosed
US-20080194444-A1 Diester-Based Lubricants and Methods of Making Same CHEVRON U.S.A. INC. (US) 2008-08-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090198075-A1 SYNTHESIS OF DIESTER-BASED BIOLUBRICANTS FROM EPOXIDES ELOVL5, ELOVL1, ELOVL3 LMNA 4543/4885MAPT 1348/4885MAPK1 3988/4885
US-20090285728-A1 ISOLATION AND SUBSEQUENT UTILIZATION OF SATURATED FATTY ACIDS AND ALPHA-OLEFINS IN THE PRODUCTION OF ESTER-BASED BIOLUBRICANTS ELOVL1, ELOVL5, FADS1 LMNA 2358/4885MAPT 1638/4885MAPK1 3418/4885
US-20080194444-A1 Diester-Based Lubricants and Methods of Making Same DGAT2, DGAT1, FADS1 LMNA 4799/4885MAPT 2489/4885MAPK1 3615/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.